September 2020 - Page 344 of 365

NASDAQ Companies - September 2, 2020

XOMA to Present at Upcoming Investor Conferences

EMERYVILLE, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, […]

TSX News - September 2, 2020

Colliers International Expands to Nashville, Tennessee

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Leading global commercial real estate services and investment management firm, Colliers International Group […]

NYSE Companies - September 2, 2020

Brown & Brown, Inc. Enters Into Agreement to Acquire Vehicle Administrative Services

DAYTONA BEACH, Fla., Sept. 02, 2020 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. […]

NASDAQ Companies - September 2, 2020

G1 Therapeutics to Participate in Four Investor Conferences in September 2020

RESEARCH TRIANGLE PARK, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today […]

NASDAQ Companies - September 2, 2020

Akoustis Appoints Former Grant Thornton, CEO, J. Michael McGuire, to its Board of Directors

Charlotte, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) […]

NASDAQ Companies - September 2, 2020

Applied Therapeutics to Present at Citi and Baird Investor Conferences

NEW YORK, Sept. 02, 2020 (GLOBE NEWSWIRE) — Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline […]

NASDAQ Companies - September 2, 2020

Imara to Present at Upcoming Investor Conferences

BOSTON, Sept. 02, 2020 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing […]